Libertas Capital Share Discussion Threads

[moogies] 25/8/2006 11:42

Yes agreed - it is dismal.

Aren't results due - last year's interims were on 26 August 2005?


M.

[blindfaith2] 25/8/2006 11:11

and August !

[tristo6] 03/8/2006 01:11

catch this:

[rambutan2] 02/8/2006 23:28

and the tumble continued through july!

[blindfaith2] 13/6/2006 16:42

yf - If the grants were at 59p it will take some recovery from today's price though.

[rambutan2] 04/6/2006 22:56

this has taken a big tumble since march.

any suggestions?

[yf23_1] 31/5/2006 18:08

Just started looking at this company.
Directors award themselves options under an unauthorised plan worth at the time 800,000.
That sounds a bit rich considering profits were only £2m.

[moogies] 09/5/2006 14:57

IGM IPO

IGM provides first and second generation mobile phone value-added servcies to users in China, Hong Kong, Macau, Malaysia and Taiwan.

IPO Details.
Issue Date H1 .........Prospectus n/a
Issue Price n/a .......Lead Broker Libertas Capital
Market Cap $0.00m .....Contact Tel [phone]
Method Placing
Sector Mobile Telecommunications
Market Aim
Amount Raised $25.00m

[northern dancer] 10/4/2006 15:23

looks like they have bagged 900k from sale of libra natural,this should be a total gain as I think they were the initial backers to the company.good news but seems to missed by the market

[moogies] 05/4/2006 17:37

"In addition to securing the funding, Empire has commenced the process to admit Zeehan Zinc Ltd. ("Zeehan") to AIM as detailed in Empire's press release dated January 31, 2006. Libertas Capital Corporate Finance Limited is financial adviser and is acting as nominated adviser and broker to Zeehan."

[moogies] 01/3/2006 11:27

Holding(s) in Company

Libertas Capital Group PLC
28 February 2006
Looks like Walker Crips have increased their holding from 6.96% on 26/9/06

M.


28 February 2006
Libertas Capital Group plc ("the Company")
Holding in Company

The company was notified on 27 February 2006 that Walker Crips UK Growth Fund
("Walker Crips") purchased 750,000 shares in the Company on 23 February 2006.

As a result of this, Walker Crips is interested in 3,648,816 ordinary shares of
1p each ("ordinary shares") in the Company, representing 8.78% of the issued
ordinary share capital.

[scumdog] 28/2/2006 10:17

Moving up nicely -:)

[moogies] 24/2/2006 10:41

Investor's Chronicle has indeed reiterated it's BUY rec.

It says broker Shore Capital expects EPS 06 of 4.4p putting it on a forward PEr of 12.5.

M.

[moogies] 17/2/2006 11:36

Wednesday February 15, 10:03 PM
Ceramic Fuel Cells Plans AIM Listing On Mar 2
Edited Press Release


LONDON (Dow Jones)--Ceramic Fuel Cells Ltd. Wednesday said it expects to admit ordinary shares of nil par value to the Alternative Investment Market on Mar. 2.

The company develops flat-plate solid oxide fuel technology which is designed to be incorporated into electrical power generation products suitable for domestic use.

Libertas Capital Corporate Finance is the adviser and Libertas Capital Securities is the broker for the company, it said.

[scumdog] 16/2/2006 13:57

Also, the "cautiously optimistic" near term outlook may have deterred buyers.

OUTLOOK

The market place for 2006 is exciting for us at Libertas Capital, not least as
continued investment in key staff is due to bear fruit this year. We have seen a
satisfactory start to the year with some notable mandates on board and an
increasing number of companies becoming new clients. Although market conditions
are inherently volatile, we remain cautiously optimistic about the near term
market outlook and confident about Libertas Capital's long term prospects.

[scumdog] 16/2/2006 13:26

SP probably held back by 250k sell earlier today.

[scumdog] 16/2/2006 13:16

Fairly big spread but not outrageous - to be expected with a company of this size.
This should be re-rated soon. Good time to get in IMO. A 50% increase in share price (from 55p)not unreasonable, given current reults and future prospects.

[scumdog] 16/2/2006 12:51

It's just appeared on mine!

[adda] 16/2/2006 12:34

great figs nice timing with hedge fund advisory business re DNA. All it needs is to appear on a few more people's radar screens............

[moogies] 16/2/2006 12:03

Prelims out today and looking good yet there doesn't seem to be much interest. Let's hope Investor's Chronicle reiterates their buy recommendation and so increase awareness:

Libertas Capital Group PLC
16 February 2006



For immediate release 16th February 2005


LIBERTAS CAPITAL GROUP PLC PRELIMINARY RESULTS
FOR THE YEAR ENDED 31 DECEMBER 2005

Libertas Capital Group plc (AIM: LBR) ('Libertas Capital' or 'the Company'), the
financial services firm, today announces preliminary results for the year ended
31 December 2005.

Financial highlights:-

• Revenue of £9.73m (2004: £4.71m), an increase of 107%
• Operating profit of £2.22m (2004: £1.02m), an increase of 118%
• Pre tax profit of £2.20m (2004: £1.03m), an increase of 114%
• Earnings per share of 3.75 pence (2004: 2.42 pence), an increase of 55%
• Net assets at year end of £6.88m (2004: £3.51m), an increase of 96%
• Debt free at the year end
• Pre tax return on equity of 32% (2004: 29%)
• Post tax return on equity of 22% (2004: 21%)

Operational highlights:-

• 12 transactions completed including IPOs on AIM, M&A transactions and
private fundraisings
• Continued investment in staff across the business to meet demand
• Expansion into Asia and North America
• Implementation of joint venture hedge fund advisory business, DNA Advisors
• Libertas Capital Securities upgraded its licence in January 2005 and
became a member of the London Stock Exchange in February 2005
• Libertas Capital Corporate Finance was appointed as Nominated Advisers in
May 2005

Commenting on the results, Jakob Kinde, Executive Chairman of Libertas Capital
Group plc, said:-

'We are delighted with the strong performance of the business in our second year
as a public company. We have continued to implement our strategy and have
expanded our corporate finance and securities businesses with new operations in
Asia and North America to offer full service capability in these growing and
important geographical markets. In addition we have established a hedge fund
advisory business, DNA Advisors Limited, which will provide us with a new client
base and an enhanced annuity income.

We continue to invest in talented people in each of our core business areas -
corporate finance, securities/distribution and research - which allows us to
provide the high quality of services expected by our clients. As a result, we
are continuing to attract further corporate and institutional clients in the UK,
Europe, the Nordic region, the US and Asia.

We look forward to 2006 with optimism, particularly with an encouraging number
of transactions in our pipeline'.



[More]

[moogies] 15/2/2006 13:12

Hedge Fund Advisory Business

Libertas Capital Group PLC
15 February 2006


For immediate release 15th February 2006

LIBERTAS CAPITAL GROUP plc

EXPANSION INTO HEDGE FUND ADVISORY BUSINESS


Libertas Capital Group plc (AIM: LBR) ("Libertas Capital" or "the Company"), the
financial services firm, is pleased to announce that it has set up a joint
venture, DNA Advisors Limited ("DNA"), a business offering hedge fund advisory
services. DNA is 70% owned by Libertas Capital and 30% by the two principals of
DNA, John Davies and Lucy Alexander.

John Davies has over twenty five years' experience in his investment banking
career with Rowe and Pitman, Brown Brothers Harriman & Co and Lehman Brothers
where he became Co-Head of Institutional Equity Sales Europe. In 1997 he joined
Credit Lyonnais in London where he was Global Head of Sales and Sales Trading.
In 2001 he co-founded Altius Partners (a specialist hedge fund and advisory
business), and then went on to set up Green Park Investment in 2004. In 2005,
together with Lucy Alexander, he co-founded DNA. John has a degree in Law from
Emmanuel College, Cambridge. As a result of this transaction, John will cease to
be a Non Executive Director of Libertas Capital from today.

Lucy Alexander has over 16 years of experience in European financial markets.
She started her career at Lehman Brothers in European equity sales in 1989 and
subsequently worked at Merrill Lynch and Salomon Brothers in a similar capacity.
In 2000 she moved to Commerzbank where she set up and headed the Italian sales
desk and was also co-head of the hedge fund sales desk. In 2004 Lucy joined
Green Park Investment, raising capital for hedge funds. In 2005 she co-founded
DNA with John Davies. Lucy has a degree in modern languages from Cambridge
University.

In addition to John Davies and Lucy Alexander, the team now comprises Brigitte
Reinert and Michelle Tully on the sales side together with Pryesh Emrith and
Barbara Travani on research. The firm primarily distributes its single manager
hedge funds and private equity products to funds of hedge funds and private
family offices in Europe and the Middle East.

Commenting on the announcement, Jakob Kinde, Executive Chairman of Libertas
Capital, said: "This is an exciting development for Libertas Capital and we are
delighted that we have attracted two well respected and experienced principals
in John Davies and Lucy Alexander. DNA will be an integral part of Libertas
Capital's strategy, offering opportunities for fundraising as well as building
up an annuity income stream. We offer a warm welcome to them both as well as the
rest of the team. As part of this transaction John will be relinquishing his
role as a Non Executive Director and we wish to thank John for his valued
contribution and wise counsel in that role".


For further information please contact:

Libertas Capital Group plc [phone]
Jakob Kinde, Executive Chairman
Henry Okereke, Chief Executive

DNA Advisors Limited
John Davies, Chief Executive [phone]

Shore Capital [phone]
Guy Peters

Grant Thornton [phone]
Graeme Thom/ Fiona Reid

Buchanan Communications [phone]
Charles Ryland /Mary-Jane Johnson


Notes to Editors

About Libertas Capital Group plc

Libertas Capital is a UK-based financial services firm offering its clients a
full range of dedicated independent Corporate Finance Advisory, Research and
Distribution services.

Corporate Finance services include advice on M&A, public and private fund
raising, private equity encompassing development capital, MBOs and MBIs,
valuation and exit strategy. In the Securities business Libertas Capital offers
research to corporate and institutional clients, via Equity Growth Research and
Libertas Capital Research, over a global distribution network. Libertas Capital
is focused on the small to mid cap market in the UK, Northern Europe, the Nordic
region, the US and Asia where the Group has gained widespread experience and
developed strong relationships.

Libertas Capital concentrates primarily on growth companies across a number of
industry sectors with a particular focus on environmental sciences, natural
resources, technology (software and business services) and medical technology.



This information is provided by RNS
The company news service from the London Stock Exchange

[moogies] 07/2/2006 20:30

Forecasts
Yr Ending Sales(£m)Pre-tax(£m) EPS PEr PEG EPS Grth. Div Yield

31-Dec-05 8.00 1.90 3.40p 16.5 0.4 +40% n/a 0.0%
31-Dec-06 11.00 2.70 4.60p 12.2 0.3 +35% n/a 0.0%
31-Dec-07 13.60 4.20 7.10p 7.9 0.1 +54% n/a 0.0%

[adda] 03/2/2006 16:02

Good post Moogies what is your take on Libertas? Going forward what can we expect re the present share price?